172 related articles for article (PubMed ID: 21094623)
1. Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation.
Crosiers D; Ceulemans B; Meeus B; Nuytemans K; Pals P; Van Broeckhoven C; Cras P; Theuns J
Parkinsonism Relat Disord; 2011 Feb; 17(2):135-8. PubMed ID: 21094623
[No Abstract] [Full Text] [Related]
2. Juvenile dystonia-parkinsonism syndrome caused by a novel p.S941Tfs1X ATP13A2 (PARK9) mutation.
Martino D; Melzi V; Franco G; Kandasamy N; Monfrini E; Di Fonzo A
Parkinsonism Relat Disord; 2015 Nov; 21(11):1378-80. PubMed ID: 26421390
[No Abstract] [Full Text] [Related]
3. Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation.
Fong CY; Rolfs A; Schwarzbraun T; Klein C; O'Callaghan FJ
Eur J Paediatr Neurol; 2011 May; 15(3):271-5. PubMed ID: 21316993
[TBL] [Abstract][Full Text] [Related]
4. ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease.
Suleiman J; Hamwi N; El-Hattab AW
Brain Dev; 2018 Oct; 40(9):824-826. PubMed ID: 29903538
[TBL] [Abstract][Full Text] [Related]
5. From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations.
Erro R; Picillo M; Manara R; Pellecchia MT; Barone P
Parkinsonism Relat Disord; 2019 Aug; 65():272-273. PubMed ID: 31151786
[No Abstract] [Full Text] [Related]
6. Ataxia-myoclonus syndrome due to a novel homozygous ATP13A2 mutation.
De Michele G; Galatolo D; Lieto M; Fico T; Saccà F; Santorelli FM; Filla A
Parkinsonism Relat Disord; 2020 Jul; 76():42-43. PubMed ID: 32559632
[No Abstract] [Full Text] [Related]
7. Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease.
Argente-Escrig H; Martinez JC; Gómez E; Balaguer A; Sevilla T; Bataller L
J Neurol Sci; 2018 Oct; 393():140-141. PubMed ID: 30193135
[No Abstract] [Full Text] [Related]
8. Complicated recessive dystonia parkinsonism syndromes.
Schneider SA; Bhatia KP; Hardy J
Mov Disord; 2009 Mar; 24(4):490-9. PubMed ID: 19185014
[TBL] [Abstract][Full Text] [Related]
9. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.
Ramirez A; Heimbach A; Gründemann J; Stiller B; Hampshire D; Cid LP; Goebel I; Mubaidin AF; Wriekat AL; Roeper J; Al-Din A; Hillmer AM; Karsak M; Liss B; Woods CG; Behrens MI; Kubisch C
Nat Genet; 2006 Oct; 38(10):1184-91. PubMed ID: 16964263
[TBL] [Abstract][Full Text] [Related]
10. ATP13A2-related juvenile-onset Parkinson disease.
Suleiman J; El-Hattab AW
Brain Dev; 2019 Feb; 41(2):223. PubMed ID: 30144971
[No Abstract] [Full Text] [Related]
11. Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.
Kruer MC; Paudel R; Wagoner W; Sanford L; Kara E; Gregory A; Foltynie T; Lees A; Bhatia K; Hardy J; Hayflick SJ; Houlden H
Neurosci Lett; 2012 Aug; 523(1):35-8. PubMed ID: 22743658
[TBL] [Abstract][Full Text] [Related]
12. Craniocervical dystonia with levodopa-responsive parkinsonism co-segregating with a pathogenic ANO3 mutation in a Taiwanese family.
Kuo MC; Lin HI; Lin CH
Parkinsonism Relat Disord; 2019 May; 62():236-238. PubMed ID: 30692049
[No Abstract] [Full Text] [Related]
13. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
[TBL] [Abstract][Full Text] [Related]
14. X-linked recessive dystonia parkinsonism (XDP; Lubag; DYT3).
Singleton A; Hague S; Hernandez D
Adv Neurol; 2004; 94():139-42. PubMed ID: 14509666
[No Abstract] [Full Text] [Related]
15. A new variant of the ATP13A2 gene in Chinese patients with early-onset parkinsonism.
Wang L; Guo JF; Nie LL; Zhang HN; Shen L; Jiang H; Pan Q; Xia K; Tang BS; Yan XX
Chin Med J (Engl); 2009 Dec; 122(24):3082-5. PubMed ID: 20137506
[No Abstract] [Full Text] [Related]
16. Novel SERAC1 mutations in a Chinese patient presenting with parkinsonism and dystonia.
Ma J; Wang L; Yang YM; Mao CH; Wan XH
Neurol Sci; 2018 May; 39(5):967-969. PubMed ID: 29332177
[No Abstract] [Full Text] [Related]
17. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
Pietrzak A; Badura-Stronka M; Kangas-Kontio T; Felczak P; Kozubski W; Latos-Bielenska A; Wierzba-Bobrowicz T; Florczak-Wyspianska J
Folia Neuropathol; 2019; 57(3):285-294. PubMed ID: 31588715
[TBL] [Abstract][Full Text] [Related]
18. Infantile parkinsonism-dystonia due to dopamine transporter gene mutations: another genetic twist.
Blackstone C
Lancet Neurol; 2011 Jan; 10(1):24-5. PubMed ID: 21112252
[No Abstract] [Full Text] [Related]
19. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
[TBL] [Abstract][Full Text] [Related]
20. [Mutation analysis of ATP13A2 gene in Chinese patients with familial autosomal recessive early-onset parkinsonism].
He D; Guo JF; Wang L; Xiao ZQ; Nie LL; Zhang XW; Tang BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):567-70. PubMed ID: 19806583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
